Secura Bio, Inc. ( an integrated pharmaceutical company maximizing commercial outcomes for oncology medicines, today ...

According to the latest analysis by DataM Intelligence, the Next-Generation Multiple Myeloma Therapies Market Size was valued at USD 22.03 billion in 2023, increased to USD 23.13 billion in 2024, and ...

Cash balance of $344.8 million as of September 30, 2025, together with net proceeds of ~$445 million from October 2025 equity offering, with expected runway into 2028 BEDFORD, Mass., Nov. 04, 2025 ...

Ad hoc announcement pursuant to Art. 53 LRComparable long-term effectiveness to standard of care corticosteroids over 5 years Normal growth ...

A malaria test commonly used across Asia and South America “is not fit for purpose”, researchers have claimed.

Q3 2025 Earnings Call November 3, 2025 4:30 PM ESTCompany ParticipantsRobert DeVitaDavid Hung - Founder, President, CEO ...

Prior authorizations (PAs) continue to be one of the biggest hurdles to timely patient care. A recent survey found that 93% of physicians say that the PA process can delay treatment and three-quarters ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today announced it will present new late-breaking data highlighting the clinical and economic ...

The pharmaceutical world offers a valuable blueprint on how to harness AI’s efficiency while protecting trust, ethics and above all, people.

Cardiologists need to know how to recognize and manage the cardiac effects that can arise from SARS-CoV-2 infections or COVID ...

Artificial Intelligence, or AI, is now transforming how we detect, prevent and treat illness, promising earlier interventions, smarter therapies and more affordable care for everyone.​ ...